Camsing Healthcare (BAC) Q3 2026 TU earnings summary

Executive summary

• 9MFY2026 revenue fell 16% YoY to S$3.043m; loss before tax narrowed to S$571k from S$665k.

• Q3FY2026 revenue was S$963k, down 5% YoY, while loss before tax narrowed to S$148k from S$253k.

Financial highlights

• 9M gross profit declined 21% YoY to S$1.633m; gross margin was 54%, versus 57% in 9MFY2025, mainly due to product mix.

• 9M other income fell 63% YoY to S$546k, mainly as prior-year loan waivers did not recur; a lease-termination gain partly offset the decline.

• 9M marketing and distribution costs decreased 49% to S$1.468m; administrative and other operating expenses rose 16% to S$1.198m.

• 9M net loss attributable to owners was S$571k; basic and diluted loss per share improved to 0.63 Singapore cents from 1.19 cents.

Outlook and guidance

• Retail restructuring began at FY2026 start, closing loss-making outlets and expanding online; most customers were retained through redirection to other outlets or digital channels.

• Online sales showed improved growth; cautious optimism for performance improvement, alongside continued product development, channel expansion and prudent cost management.